Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Adagen Articles

Italy’s Sigma-Tau to takeover Enzon business for some $327 million in cash plus royalties

10 November 2009

Enzon Pharma explores options, including the sale of its specialty drugs unit

18 August 2008

Enzon swings to $286M loss in 4th-qtr 2005

13 March 2006

NPS Pharma and Enzon to merge in $1.6B deal; aim to be "a new biotech leader"

3 March 2003

Enzon - improving the delivery and side effect profile of proven

20 January 1999

Cortex, Enzon And Mylan Results

11 September 1997

ENZON'S ONCASPAR APPROVED IN USA

14 February 1994

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • New study shows UCB's Neupro reduces NSBP in RLS patient
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • New study shows UCB's Neupro reduces NSBP in RLS patient

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS